Change Language

Select Language

Press Release:

Global Bioburden Testing Market to Grow at 12.44% During 2022-2027, Spurred by Rapid Outbreak of COVID-19

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Bioburden Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global bioburden testing market is expected to exhibit a CAGR of 12.44% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Bioburden testing assists in measuring the total viable count of microbial contamination in a product. It is widely used in the pharmaceutical industry to understand the different types and amounts of microorganisms in sterile medical devices throughout the production process. Prior to the test, a suitability experiment is usually conducted to ensure the effectiveness of the testing method while recovering the microorganisms present on the device.

Bioburden Testing Market Trends:

At present, the governing authorities of numerous countries are implementing stringent regulatory norms to validate the sterilization process of medical devices. This represents one of the leading factors escalating the demand for bioburden testing to meet microbial quality and sterilization requirements of medical devices. Moreover, bioburden testing can be performed on devices as a part of the routine quality control process. Apart from this, major pharmaceutical manufacturers are focusing on producing safe products and achieving sterility assurance. This, in confluence with the rising utilization of single-use medical items, is influencing the market positively. Furthermore, as bioburden testing is an integral part of the microbiological monitoring program while manufacturing sterile products, it is gaining recognition in the cosmetics industry for maintaining the overall safety and performance of the packaged goods. Additionally, the surge in coronavirus disease (COVID-19) cases is escalating the need for bioburden reduction systems that utilize dry heat to support the reuse of particulate filtering facepiece respirators (FFRs). This, along with the growing food safety standards, is anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bioburden testing market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, test type, application and end user.

Breakup by Product:

  • Consumables
    • Culture Media
    • Reagents
    • Others
  • Instruments
    • Automated Microbial Identification Systems
    • Polymerase Chain Reaction Systems
    • Microscopes
    • Others
       

Breakup by Test Type:

  • Aerobic Count Testing
  • Anaerobic Count Testing
  • Fungi/Mold Count Testing
  • Spores Count Testing
  • Others
     

Breakup by Application:

  • Raw Material Testing
  • Medical Devices Testing
  • In-process Testing
  • Sterilization Validation Testing
  • Others
     

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Contract Manufacturing Organizations (CMOs)
  • Food and Beverages Companies
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, Biomérieux SA (Compagnie Merieux Alliance), Charles River Laboratories Inc, Merck KGaA, Nelson Laboratories LLC (Sotera Health LLC), North American Science Associates Inc., Pacific BioLabs Inc., SGS SA, Thermo Fisher Scientific Inc and Wuxi Apptec.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Test Type, Application, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Becton Dickinson and Company, Biomérieux SA (Compagnie Merieux Alliance), Charles River Laboratories Inc, Merck KGaA, Nelson Laboratories LLC (Sotera Health LLC), North American Science Associates Inc., Pacific BioLabs Inc., SGS SA, Thermo Fisher Scientific Inc and Wuxi Apptec
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Bioburden Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Major Types
           6.1.2.1 Culture Media
           6.1.2.2 Reagents
           6.1.2.3 Others
        6.1.3 Market Forecast
    6.2    Instruments
        6.2.1 Market Trends
        6.2.2 Major Types
           6.2.2.1 Automated Microbial Identification Systems
           6.2.2.2 Polymerase Chain Reaction Systems
           6.2.2.3 Microscopes
           6.2.2.4 Others
        6.2.3 Market Forecast
7   Market Breakup by Test Type
    7.1    Aerobic Count Testing
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Anaerobic Count Testing
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Fungi/Mold Count Testing
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Spores Count Testing
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Application
    8.1    Raw Material Testing
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Medical Devices Testing
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    In-process Testing
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Sterilization Validation Testing
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by End User
    9.1    Pharmaceutical and Biotechnology Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Medical Device Companies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Contract Manufacturing Organizations (CMOs)
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Food and Beverages Companies
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Becton Dickinson and Company
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Biomérieux SA (Compagnie Merieux Alliance)
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Charles River Laboratories Inc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Merck KGaA
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Nelson Laboratories LLC (Sotera Health LLC)
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    North American Science Associates Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Pacific BioLabs Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    SGS SA
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
        15.3.9    Thermo Fisher Scientific Inc
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Wuxi Apptec
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio

List of Figures

Figure 1: Global: Bioburden Testing Market: Major Drivers and Challenges
Figure 2: Global: Bioburden Testing Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Bioburden Testing Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Bioburden Testing Market: Breakup by Product (in %), 2021
Figure 5: Global: Bioburden Testing Market: Breakup by Test Type (in %), 2021
Figure 6: Global: Bioburden Testing Market: Breakup by Application (in %), 2021
Figure 7: Global: Bioburden Testing Market: Breakup by End User (in %), 2021
Figure 8: Global: Bioburden Testing Market: Breakup by Region (in %), 2021
Figure 9: Global: Bioburden Testing (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Bioburden Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Bioburden Testing (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Bioburden Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Bioburden Testing (Aerobic Count Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Bioburden Testing (Aerobic Count Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Bioburden Testing (Anaerobic Count Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Bioburden Testing (Anaerobic Count Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Bioburden Testing (Fungi/Mold Count Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Bioburden Testing (Fungi/Mold Count Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Bioburden Testing (Spores Count Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Bioburden Testing (Spores Count Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Bioburden Testing (Other Test Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Bioburden Testing (Other Test Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Bioburden Testing (Raw Material Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Bioburden Testing (Raw Material Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Bioburden Testing (Medical Devices Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Bioburden Testing (Medical Devices Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Bioburden Testing (In-process Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Bioburden Testing (In-process Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Bioburden Testing (Sterilization Validation Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Bioburden Testing (Sterilization Validation Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Bioburden Testing (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Bioburden Testing (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Bioburden Testing (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Bioburden Testing (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Bioburden Testing (Medical Device Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Bioburden Testing (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Bioburden Testing (Contract Manufacturing Organizations-CMOs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Bioburden Testing (Contract Manufacturing Organizations-CMOs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Bioburden Testing (Food and Beverages Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Bioburden Testing (Food and Beverages Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Bioburden Testing (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Bioburden Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia-Pacific: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia-Pacific: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Bioburden Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Bioburden Testing Market: Breakup by Country (in %), 2021
Figure 91: Middle East and Africa: Bioburden Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Global: Bioburden Testing Industry: SWOT Analysis
Figure 93: Global: Bioburden Testing Industry: Value Chain Analysis
Figure 94: Global: Bioburden Testing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Bioburden Testing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Bioburden Testing Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Bioburden Testing Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
Table 4: Global: Bioburden Testing Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Bioburden Testing Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Bioburden Testing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Bioburden Testing Market: Competitive Structure
Table 8: Global: Bioburden Testing Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

We expect the global bioburden testing market to exhibit a CAGR of 12.44% during 2022-2027.

The increasing demand for bioburden testing as a routine quality control process for medical devices, along with the growing focusing on producing safe products and achieving sterility assurance, is primarily driving the global bioburden testing market.

The sudden outbreak of the COVID-19 pandemic has led to the rising demand for bioburden testing to meet the sterilization requirement of medical devices for ensuring the safety of testing kits and drugs that are being developed to treat the coronavirus infection.

Based on the product, the global bioburden testing market has been segmented into consumables and instruments, where consumables currently hold the majority of the total market share.

Based on the test type, the global bioburden testing market can be divided into aerobic count testing, anaerobic count testing, fungi/mold count testing, spores count testing, and others. Currently, aerobic count testing exhibits a clear dominance in the market.

Based on the application, the global bioburden testing market has been categorized into raw material testing, medical devices testing, in-process testing, sterilization validation testing, and others. Among these, raw material testing currently accounts for the majority of the global market share.

Based on the end user, the global bioburden testing market can be segregated into pharmaceutical and biotechnology companies, medical device companies, Contract Manufacturing Organizations (CMOs), food and beverages companies, and others. Currently, Contract Manufacturing Organizations (CMOs) hold the largest market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global bioburden testing market include Becton Dickinson and Company, Biomérieux SA (Compagnie Merieux Alliance), Charles River Laboratories Inc, Merck KGaA, Nelson Laboratories LLC (Sotera Health LLC), North American Science Associates Inc., Pacific BioLabs Inc., SGS SA, Thermo Fisher Scientific Inc, and Wuxi Apptec.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028

Read More

Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028

Read More

Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028

Read More

IgA Nephropathy (IgAN) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Read More

Triple-negative Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links

4